Tubeless Insulin Pump Market - Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2029
Overview
Tubeless Insulin Pump Market size is expected to grow at a CAGR of 21.2% during the forecast period and the market size is expected to reach nearly US$ 9.77 Bn. by 2029.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. 
To know about the Research Methodology :- Request Free Sample Report
Escalating prevalence of diabetes and obesity, growing geriatric population and technological advances in tubeless insulin delivery should drive the market size. According to WHO, diabetes will be the among the leading causes of death by 2029. These factors will prominently intensify the global usage of tubeless insulin pump over the forecast period. Lifestyle changes shall continue to impact obesity prevalence in western as well as non-western population. Cultural switch from native diets to high fatty diet should increase the propensity to get affected by diabetes and obesity surging up demand for the tubeless insulin pump.
Technological advances in the field of glucose monitoring devices and tubeless insulin pump should stimulate business growth over the forecast years. A tubeless insulin pump is convenient, portable and effective in achieving better blood glucose level control, eliminating the need for daily insulin injection doses. Devices such as Omni pod is a novel tubeless insulin pump which displays blood glucose levels, schedules insulin delivery and calculates optimal insulin dosage based on the food database. Increased adoption of non-invasive transdermal insulin delivery systems has improved patient compliance for diabetes treatment. Use of microneedles and micro-emulsions improves permeation of insulin through the transdermal route. Other effective routes of insulin administration such as oral, buccal, nasal is explored as alternative non-invasive modes of delivery.
The Pod/patch market accounted for the largest market share in 2022 and is forecast to witness considerable growth over the forecast years. Improvement in pod’s size and functions will drive tubeless insulin pump demand over the coming years. The need to regularly change a remote is spurring demand for these devices. Incremental innovation to design remote which can control pump functions from the distant location will accelerate its usage over the coming years.
North America Tubeless Insulin Pump Market accounted for the highest revenue in 2022 and is projected to grow at a significant rate during the forecast period. U.S. Tubeless Insulin Pump Market accounted for a largest regional share in 2022. Diabetes prevalence is escalating due to the increasing aging population, rapid urbanization and increasing cases of obesity due to lack of physical inactivity. The anticipated rising demand for tubeless insulin pump should strongly drive regional business growth.
Maximize Market Research has comprehensively analyzed Tubeless Insulin Pump Market emphasizing on each segment keeping global and regional dynamics in perspective. The driving forces, as well as considerable restraints, have been explained in depth to attain a balanced scenario. The report classifies Tubeless Insulin Pump Market into various segments such as Component, Distribution Channel, and Regions providing the thorough understanding of the Tubeless Insulin Pump Ecosystem. Importantly, the report delivers forecasts of the market, giving an insight into the future opportunities that exist in the Tubeless Insulin Pump Market.
The objective of the report is to present comprehensive Tubeless Insulin Pump Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
The report also helps in understanding Tubeless Insulin Pump Market North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Tubeless Insulin Pump Market North America for Asia Pacific size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Tubeless Insulin Pump Market North America for Asia Pacific make the report investor’s guide.
Tubeless Insulin Pump Market Scope: Inquire before buying
| Global Tubeless Insulin Pump Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2018 to 2022 | Market Size in 2022: | US $ 2.54 Bn. |
| Forecast Period 2023 to 2029 CAGR: | 21.2% | Market Size in 2029: | US $ 9.77 Bn. |
| Segments Covered: | by Component | Pod/Patch Remote Others |
|
| by Distribution Channel | Hospitals Pharmacies e-Commerce Others |
||
Tubeless Insulin Pump Market, by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Tubeless Insulin Pump Market Key Players:
1. Insulet Corporation
2. Johnson & Johnson
3. Medtrum Technologies
4. Cellnova
5. Roche Holdings
6. Spring Health Solutions
7. Debiotech
8. CeQur
9. Valeritas Holding
10.Abbott Diabetes Care
11.Medtronic Plc.
12.Tandem Diabetes Care
13.Insulet Corporation
14.Animas Corporation
Frequently Asked Questions:
1. Which region has the largest share in Global Tubeless Insulin Pump Market?
Ans: North America region holds the highest share in 2022.
2. What is the growth rate of Global Tubeless Insulin Pump Market?
Ans: The Global Market is growing at a CAGR of 21.2% during forecasting period 2023-2029.
3. What is scope of the Global Tubeless Insulin Pump market report?
Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Tubeless Insulin Pump market?
Ans: The important key players in the Global Market are – Insulet Corporation, Johnson & Johnson, Medtrum Technologies, Cellnova, Roche Holdings, Spring Health Solutions, Debiotech, CeQur, Valeritas Holding, Abbott Diabetes Care, Medtronic Plc., Tandem Diabetes Care, Insulet Corporation, and Animas Corporation
5. What is the study period of this market?
Ans: The Global Market is studied from 2022 to 2029.